AdDIT

Biomarkers associated with early stages of kidney disease in adolescents with type 1 diabetes

By Graham|2023-02-06T12:31:57-08:00February 6, 2023|Comments Off

Medication Adherence During Adjunct Therapy With Statins and ACE Inhibitors in Adolescents With Type 1 Diabetes.

By Graham|2023-02-06T12:30:06-08:00February 6, 2023|Comments Off

Vascular Effects of ACE (Angiotensin-Converting Enzyme) Inhibitors and Statins in Adolescents With Type 1 Diabetes

By Graham|2023-02-06T12:28:04-08:00February 6, 2023|Comments Off

Comparison of Clinical and Social Characteristics of Canadian Youth Living with Type 2 and Type 1 Diabetes

By Graham|2022-12-15T16:01:47-08:00December 15, 2022|Comments Off

Evaluation of novel glomerular filtration rate estimation equations in adolescents and young adults with type 1 diabetes

By Graham|2022-12-15T15:49:17-08:00December 15, 2022|Comments Off

Relationship between serum inflammatory markers and vascular function in a cohort of adolescents with type 1 diabetes

By Graham|2022-03-29T14:24:35-07:00March 29, 2022|Comments Off

Hyperfiltration, urinary albumin excretion, and ambulatory blood pressure in adolescents with Type 1 diabetes mellitus

By Graham|2022-03-25T15:45:20-07:00March 25, 2022|Comments Off

303F – 1125 Howe Street

Vancouver, BC, Canada, V6Z 2K8

604.682.2344 ext. 64025

info@cansolveckd.ca

The Can-SOLVE CKD Network acknowledges that our offices are located on the traditional, unceded territory of the Coast Salish Peoples, home of the Musqueam, Tsleil-Waututh, and Squamish First Nations.

© 2023 Can-SOLVE CKD Network. All rights reserved.